Bright Health reduced its revenue guidance for the year as the soon-to-be former health insurer advances the sale of its final insurance asset, the company reported Wednesday.
The company downgraded its annual revenue guidance from $2.9 billion-$3.1 billion to $1.15 billion-$1.2 billion. Bright Health narrowed its net loss 56% to $125 million, or $15.70 per share, as revenue nearly doubled to $298 million.
Related: Bright Health receives…